Research & Publications
Dr. Hawk's research primarily focuses on reducing substance use disorder associated morbidity and mortality in high risk populations, with an emphasis on opioid overdose prevention, harm reduction and linkage to treatment initiation for emergency department patients with opioid or alcohol use disorder.
Extensive Research Description
Kathryn Hawk, MD, MHS is an Associate Professor in the Department of Emergency Medicine and an attending physician in the Yale New Haven Hospital Emergency Department. She is a former NIDA sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on reducing opioid-associated morbidity and mortality in high risk populations, with an emphasis on opioid overdose prevention, harm reduction and linkage to treatment for ED patients with opioid use disorder. Her research has been supported by National Institute on Drug Abuse (NIDA), the NIDA Clinical Trials Network, Centers for Disease Control (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the Food and Drug Administration (FDA) and includes reducing opioid-associated mortality through data linkages, implementation-facilitation of ED initiation buprenorphine, naloxone distribution, ED patient experience and reported outcomes, and dissemination of evidence-based best practices for care of patients with addiction.
Bioethics; Buprenorphine; Opioid-Related Disorders; Alcohol-Related Disorders; Harm Reduction; Addiction Medicine; Implementation Science; Opiate Overdose
Public Health Interests
Substance Use, Addiction; Health Equity, Disparities, Social Determinants and Justice; Qualitative Methods
- Ability to Reach Low-Income Smokers Enrolled in a Randomised Controlled Trial Varies with Time of MonthHawk, K., Shi, R., Weiss, J., Makuch, R., Toll, B., & Bernstein, S. (2017). Ability to Reach Low-Income Smokers Enrolled in a Randomised Controlled Trial Varies with Time of Month. Journal of Smoking Cessation, 1-6. doi:10.1017/jsc.2017.23